Popular Articles

New Treatment Approach Gives Patients With Incurable Lung Cancer More Time Without Disease Progression Compared To Placebo
Results from a Phase III study presented at the American Society for Clinical Oncology (ASCO) Annual Meeting in Orlando, Florida today show that patients with advanced non-small cell lung cancer (NSCLC) who received erlotinib (Tarceva®) as first-line maintenance treatment benefited from a significant (29%) improvement in the time they lived without the disease advancing, compared with those who received placebo1. Patients in the global multicentre SATURN trial, which included patients from the UK, received maintenance treatment with erlotinib if their cancer had not progressed on initial chemotherapy. The data showed a significant improvement in the length of time patients lived without their disease getting worse, and without the need for further chemotherapy. 1 The improvement was seen in both of the main types of NSCLC (squamous cell as well as non-squamous cell) and these results form the basis of a submission for regulatory approval of erlotinib to be used in the first-line maintenance setting. 1 Erlotinib is not currently licensed for first line maintenance treatment in NSCLC lung cancer in the UK.
generic viagra online
Processing In The Brain's Reward Pathways May Be Affected By Childhood Adversity
New research shows that childhood adversity is associated with diminished neural activity in brain regions implicated in the anticipation of possible rewards.
News of the day
Neighborhood Violence Affects Disadvantaged Youth And The Influence Of Family And Religion On Youth Delinquency
Research published in the June issue of the American Sociological Review examines issues surrounding families, communities, youth and delinquency. The following briefs highlight selected sociological findings.
Health Insurance

Family History Predicts Presence And Course Of Psychiatric Disorders

A family history of depression, anxiety, alcohol dependence or drug dependence is associated with the presence of each condition and also may predict its course and prognosis, according to a report in the July issue of Archives of General Psychiatry, one of the JAMA/Archives journals. Family history of a psychiatric condition is generally known to increase an individual"s risk of developing that condition, according to background information in the article. "However, there is a need to go further and test whether family history is also associated with clinical features of the disorder thought to represent a continuum of seriousness among individuals who meet criteria for diagnosis," the authors write. Barry J. Milne, Ph.D., of University of Auckland, New Zealand, and colleagues studied 981 residents of Dunedin, New Zealand, born in 1972 or 1973. Participants were enrolled in the Dunedin Study at age 3 and followed up through age 32. Between 2003 and 2005, family history data were collected about each individual"s biological parents, grandparents and siblings older than 10 years. Four psychiatric disorders were studied: major depressive episode, anxiety disorder, alcohol dependence and drug dependence. "In general, we found that associations showed a consistent direction of effect across all four disorders: (1) family history was associated with the presence vs. absence of disorder for all four disorder types; (2) family history was associated with a recurrent course for all four disorders (but not significantly for women with depression); (3) family history was associated with worse impairment for all four disorders (but not significantly for depression and drug dependence); and (4) family history was associated with greater service use for all four disorders (but not significantly for anxiety disorders)," the authors write. The results suggest implications for researchers who wish to study genetic forms of a disorder and also for clinicians treating psychiatric conditions, the authors note. From a public health perspective, family history may be useful for determining which patients will have the poorest prognosis," they conclude. "For example, among those with depression, anxiety disorder, alcohol dependence and drug dependence, a family history screen may help determine whose illness will recur, whose illness will cause the greatest impairment and who will be the most likely to use treatment res. Thus, family history may identify a subgroup in need of primary or early intervention, and for whom treatments appropriate for recurrent, highly disabling disorder may be needed." Arch Gen Psychiatry. 2009;66[7]:738-747. Archives of General Psychiatry


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):